Breaking News Instant updates and real-time market news.

SJM

J.M. Smucker

$116.11 /

-0.13 (-0.11%)

07:00
11/24/20
11/24
07:00
11/24/20
07:00

J.M. Smucker reports Q2 adjusted EPS $2.39, consensus $2.23

Reports Q2 revenue $2.03B, consensus $2.01B.

  • 24

    Nov

SJM J.M. Smucker
$116.11 /

-0.13 (-0.11%)

09/16/20 Morgan Stanley
J.M. Smucker price target lowered to $106 from $114 at Morgan Stanley
08/26/20
Fly Intel: Top five analyst upgrades
08/26/20 Deutsche Bank
J.M. Smucker price target raised to $127 from $121 at Deutsche Bank
08/26/20 Guggenheim
Guggenheim upgrades J.M. Smucker to Neutral after 'beat and raise' report

TODAY'S FREE FLY STORIES

Downgrade
Take-Two downgraded to Neutral from Buy at UBS » 07:42
01/19/21
01/19
07:42
01/19/21
07:42
TTWO

Take-Two

$196.32 /

+0.87 (+0.45%)

UBS analyst Eric Sheridan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TTWO Take-Two
$196.32 /

+0.87 (+0.45%)

TTWO Take-Two
$196.32 /

+0.87 (+0.45%)

01/14/21 MKM Partners
Take-Two downgraded to Neutral from Buy at MKM Partners
01/14/21 Deutsche Bank
Take-Two price target raised to $240 from $200 at Deutsche Bank
01/13/21
Fly Intel: Top five analyst downgrades
01/13/21 KeyBanc
Take-Two downgraded to Sector Weight on FY22 slate questions at KeyBanc
TTWO Take-Two
$196.32 /

+0.87 (+0.45%)

TTWO Take-Two
$196.32 /

+0.87 (+0.45%)

TTWO Take-Two
$196.32 /

+0.87 (+0.45%)

TTWO Take-Two
$196.32 /

+0.87 (+0.45%)

Syndicate
Athira Pharma files to sell 4M shares of common stock » 07:41
01/19/21
01/19
07:41
01/19/21
07:41
ATHA

Athira Pharma

$26.47 /

-0.43 (-1.60%)

Goldman, Jefferies and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATHA Athira Pharma
$26.47 /

-0.43 (-1.60%)

ATHA Athira Pharma
$26.47 /

-0.43 (-1.60%)

10/13/20 Jefferies
Athira Pharma initiated with a Buy at Jefferies
10/13/20 JMP Securities
Athira Pharma initiated with an Outperform at JMP Securities
10/13/20 Stifel
Athira Pharma initiated with a Buy at Stifel
10/13/20 Goldman Sachs
Athira Pharma initiated with a Buy at Goldman Sachs
ATHA Athira Pharma
$26.47 /

-0.43 (-1.60%)

  • 18
    Sep
Downgrade
Editas Medicine downgraded to Underweight from Equal Weight at Morgan Stanley » 07:41
01/19/21
01/19
07:41
01/19/21
07:41
EDIT

Editas Medicine

$76.07 /

+0.19 (+0.25%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EDIT Editas Medicine
$76.07 /

+0.19 (+0.25%)

EDIT Editas Medicine
$76.07 /

+0.19 (+0.25%)

01/13/21 Wells Fargo
Editas Medicine price target raised to $86 from $69 at Wells Fargo
01/08/21 Raymond James
Editas downgraded to Market Perform at Raymond James (Thursday morning)
01/07/21 Raymond James
Editas Medicine downgraded to Market Perform from Outperform at Raymond James
12/10/20
Fly Intel: Top five analyst upgrades
EDIT Editas Medicine
$76.07 /

+0.19 (+0.25%)

  • 24
    Jun
EDIT Editas Medicine
$76.07 /

+0.19 (+0.25%)

EDIT Editas Medicine
$76.07 /

+0.19 (+0.25%)

EDIT Editas Medicine
$76.07 /

+0.19 (+0.25%)

Hot Stocks
CorVel, ReedGroup partner to offer integrated disability management » 07:41
01/19/21
01/19
07:41
01/19/21
07:41
CRVL

CorVel

$105.12 /

-0.41 (-0.39%)

The companies said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRVL CorVel
$105.12 /

-0.41 (-0.39%)

Hot Stocks
Frequency Therapeutics appoints Quentin McCubbin as chief manufacturing officer » 07:40
01/19/21
01/19
07:40
01/19/21
07:40
FREQ

FREQ

/

+

, CERE

Cerevel Therapeutics

$14.46 /

-0.59 (-3.92%)

Frequency Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FREQ FREQ
/

+

CERE Cerevel Therapeutics
$14.46 /

-0.59 (-3.92%)

FREQ FREQ
/

+

12/22/20 B. Riley Securities
Frequency Therapeutics initiated with a Buy at B. Riley Securities
12/16/20 Oppenheimer
Frequency Therapeutics price target raised to $48 from $36 at Oppenheimer
07/13/20 Oppenheimer
Frequency Therapeutics initiated with an Outperform at Oppenheimer
05/18/20 JPMorgan
JPMorgan downgrades Frequency Therapeutics on unclear data timelines
CERE Cerevel Therapeutics
$14.46 /

-0.59 (-3.92%)

12/10/20 Goldman Sachs
Cerevel Therapeutics initiated with a Buy at Goldman Sachs
11/23/20 Jefferies
Cerevel Therapeutics initiated with a Buy at Jefferies
11/09/20
Fly Intel: Top five analyst initiations
11/09/20 Stifel
Cerevel Therapeutics initiated with a Buy at Stifel
FREQ FREQ
/

+

Downgrade
Peloton downgraded to Sell from Neutral at UBS » 07:40
01/19/21
01/19
07:40
01/19/21
07:40
PTON

Peloton

/

+

UBS analyst Eric Sheridan…

UBS analyst Eric Sheridan downgraded Peloton Interactive to Sell from Neutral with a price target of $124, up from $115. The stock is "emblematic of a market that values growth over any semblance of valuation that can be justified" on a multiple year view based on fundamentals, Sheridan tells investors in a research note. The analyst thinks investors "need to be wary of the rising trend of bull market optimism" in a handful of businesses that have been either COVID-19 "beneficiaries" or have come to the public markets over the last 18 months. He sees a negative risk/reward skew for Peloton shares at current levels.

ShowHide Related Items >><<
PTON Peloton
/

+

PTON Peloton
/

+

01/08/21
Fly Intel: Top five analyst initiations
01/08/21 Gordon Haskett
Peloton initiated with a Buy at Gordon Haskett
01/05/21 Stifel
Stifel adds Vroom to Select List, removes Buy-rated Peloton
01/04/21 Barclays
Peloton assumed with an Overweight at Barclays
PTON Peloton
/

+

PTON Peloton
/

+

PTON Peloton
/

+

PTON Peloton
/

+

General news
Treasury Market Outlook: U.S. equity futures are reopening with a bullish tone » 07:40
01/19/21
01/19
07:40
01/19/21
07:40

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Gilat Satellite awarded contracts for cellular backhaul projects in Mexico » 07:39
01/19/21
01/19
07:39
01/19/21
07:39
GILT

Gilat Satellite

$7.32 /

-0.17 (-2.27%)

Gilat Satellite Networks…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILT Gilat Satellite
$7.32 /

-0.17 (-2.27%)

GILT Gilat Satellite
$7.32 /

-0.17 (-2.27%)

GILT Gilat Satellite
$7.32 /

-0.17 (-2.27%)

Downgrade
Fiverr downgraded to Sell from Neutral at UBS » 07:39
01/19/21
01/19
07:39
01/19/21
07:39
FVRR

Fiverr

$267.03 /

-3.195 (-1.18%)

UBS analyst Eric Sheridan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FVRR Fiverr
$267.03 /

-3.195 (-1.18%)

FVRR Fiverr
$267.03 /

-3.195 (-1.18%)

01/12/21 Citi
Fiverr price target raised to $270 from $185 at Citi
12/21/20 Goldman Sachs
Fiverr initiated with a Buy at Goldman Sachs
11/20/20 Needham
Fiverr price target raised to $210 from $180 at Needham
11/18/20 BTIG
Upwork price target raised to $42 from $27 at BTIG
FVRR Fiverr
$267.03 /

-3.195 (-1.18%)

  • 29
    May
FVRR Fiverr
$267.03 /

-3.195 (-1.18%)

FVRR Fiverr
$267.03 /

-3.195 (-1.18%)

Downgrade
Chewy downgraded to Sell from Neutral at UBS » 07:39
01/19/21
01/19
07:39
01/19/21
07:39
CHWY

Chewy

$108.05 /

-6.57 (-5.73%)

UBS analyst Eric Sheridan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
CHWY Chewy
$108.05 /

-6.57 (-5.73%)

CHWY Chewy
$108.05 /

-6.57 (-5.73%)

01/13/21 Credit Suisse
Chewy price target raised to $121 from $104 at Credit Suisse
01/04/21 Barclays
Chewy assumed with an Equal Weight at Barclays
12/18/20 William Blair
Chewy share growth should stabilize at 20%-25%, says William Blair
12/17/20 Needham
Chewy price target raised to $110 from $90 at Needham
CHWY Chewy
$108.05 /

-6.57 (-5.73%)

  • 17
    Sep
CHWY Chewy
$108.05 /

-6.57 (-5.73%)

CHWY Chewy
$108.05 /

-6.57 (-5.73%)

CHWY Chewy
$108.05 /

-6.57 (-5.73%)

Hot Stocks
Brickell announces Japan Phase 3 study results for sofpironium bromide gel » 07:38
01/19/21
01/19
07:38
01/19/21
07:38
BBI

Brickell Biotech

$1.10 /

+0.03 (+2.80%)

Brickell Biotech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBI Brickell Biotech
$1.10 /

+0.03 (+2.80%)

BBI Brickell Biotech
$1.10 /

+0.03 (+2.80%)

09/25/20 Lake Street
Approval in Japan validating for Brickell Biotech, says Lake Street
08/28/20 Lake Street
Brickell Biotech initiated with a Buy at Lake Street
08/25/20 Oppenheimer
Brickell Biotech initiated with an Outperform at Oppenheimer
  • 23
    Oct
  • 18
    Jun
Hot Stocks
Heat Biologics commences manufacturing process for ZVX-60 » 07:37
01/19/21
01/19
07:37
01/19/21
07:37
HTBX

Heat Biologics

$6.36 /

+0.15 (+2.42%)

Heat Biologics announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HTBX Heat Biologics
$6.36 /

+0.15 (+2.42%)

HTBX Heat Biologics
$6.36 /

+0.15 (+2.42%)

12/24/20 B. Riley Securities
Heat Biologics transferred with a Buy at B. Riley Securities
10/14/20
Fly Intel: Top five analyst initiations
10/14/20 B. Riley Securities
B. Riley sees 200% upside in 'value vaccine play' Heat Biologics
10/14/20 B. Riley Securities
Heat Biologics initiated with a Buy at B. Riley Securities
HTBX Heat Biologics
$6.36 /

+0.15 (+2.42%)

HTBX Heat Biologics
$6.36 /

+0.15 (+2.42%)

Hot Stocks
Ashland to acquire personal care business from Schulke & Mayr for EUR262.5M » 07:37
01/19/21
01/19
07:37
01/19/21
07:37
ASH

Ashland

$84.99 /

-1.33 (-1.54%)

, EQT

EQT Corporation

$18.50 /

+0.59 (+3.29%)

Ashland Global Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASH Ashland
$84.99 /

-1.33 (-1.54%)

EQT EQT Corporation
$18.50 /

+0.59 (+3.29%)

ASH Ashland
$84.99 /

-1.33 (-1.54%)

07:18 Today Deutsche Bank
Ashland named 'Catalyst Call: Buy Idea' at Deutsche Bank
10/09/20 Deutsche Bank
Deutsche initiates 'Buy Catalyst Call' on Ashland ahead of results
09/22/20 Evercore ISI
Ashland initiated with an In Line at Evercore ISI
08/24/20 JPMorgan
Ashland price target raised to $75 from $62 at JPMorgan
EQT EQT Corporation
$18.50 /

+0.59 (+3.29%)

01/11/21 Mizuho
EQT Corporation price target lowered to $19 from $28 at Mizuho
12/15/20
Fly Intel: Top five analyst initiations
12/15/20 BofA
EQT Corporation initiated with a Buy at BofA
12/08/20 JPMorgan
EQT Corporation downgraded to Neutral with $17 target at JPMorgan
ASH Ashland
$84.99 /

-1.33 (-1.54%)

EQT EQT Corporation
$18.50 /

+0.59 (+3.29%)

  • 17
    Nov
  • 28
    Oct
EQT EQT Corporation
$18.50 /

+0.59 (+3.29%)

EQT EQT Corporation
$18.50 /

+0.59 (+3.29%)

Upgrade
Morgan Stanley upgrades Gilead to Overweight at start of 'pivotal pipeline year' » 07:35
01/19/21
01/19
07:35
01/19/21
07:35
GILD

Gilead

$63.35 /

+0.95 (+1.52%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$63.35 /

+0.95 (+1.52%)

GILD Gilead
$63.35 /

+0.95 (+1.52%)

06:01 Today Morgan Stanley
Gilead upgraded to Overweight from Equal Weight at Morgan Stanley
01/11/21 Piper Sandler
Piper says hard for Gilead investors to ascribe long-term value to Veklury
01/04/21 Guggenheim
Gilead upgraded to Buy from Neutral at Guggenheim
12/22/20 Citi
Gilead price target lowered to $72 from $75 at Citi
GILD Gilead
$63.35 /

+0.95 (+1.52%)

GILD Gilead
$63.35 /

+0.95 (+1.52%)

GILD Gilead
$63.35 /

+0.95 (+1.52%)

GILD Gilead
$63.35 /

+0.95 (+1.52%)

Options
Unusual call flow in option market yesterday » 07:35
01/19/21
01/19
07:35
01/19/21
07:35
SLQT

SelectQuote

$23.55 /

+0.98 (+4.34%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
10/06/20 Citi
Walmart entry a 'significant competitive threat' to eHealth, says Citi
09/08/20 Credit Suisse
SelectQuote price target lowered to $31 from $38 at Credit Suisse
07/01/20 SVB Leerink
SVB Leerink bullish on Benefytt Technologies, initiates with an Outperform
SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

  • 21
    May
SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

SLQT SelectQuote
$23.55 /

+0.98 (+4.34%)

Recommendations
AMN Healthcare price target raised to $81 from $72 at BMO Capital » 07:34
01/19/21
01/19
07:34
01/19/21
07:34
AMN

AMN Healthcare

$72.10 /

+0.075 (+0.10%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
AMN AMN Healthcare
$72.10 /

+0.075 (+0.10%)

11/06/20 Truist
AMN Healthcare price target raised to $78 from $68 at Truist
11/06/20 Credit Suisse
AMN Healthcare price target raised to $76 from $63 at Credit Suisse
10/08/20 BofA
AMN Healthcare initiated with a Buy at BofA
08/07/20 BMO Capital
AMN Healthcare price target raised to $65 from $50 at BMO Capital
AMN AMN Healthcare
$72.10 /

+0.075 (+0.10%)

Earnings
Kforce expects EPS to exceed 78c per share, consensus 75c » 07:34
01/19/21
01/19
07:34
01/19/21
07:34
KFRC

Kforce

$42.70 /

-1.28 (-2.91%)

Sees revenue exceeding…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KFRC Kforce
$42.70 /

-1.28 (-2.91%)

01/04/21 Sidoti
Kforce upgraded to Buy from Neutral at Sidoti
08/11/20 Truist
Kforce price target raised to $35 from $30 at Truist
08/11/20 William Blair
Kforce upgraded to Outperform from Market Perform at William Blair
05/28/20 Sidoti
Kforce downgraded to Neutral from Buy at Sidoti
KFRC Kforce
$42.70 /

-1.28 (-2.91%)

KFRC Kforce
$42.70 /

-1.28 (-2.91%)

Hot Stocks
Pembina Pipeline announces binding open season » 07:34
01/19/21
01/19
07:34
01/19/21
07:34
PBA

Pembina Pipeline

$27.39 /

-0.5 (-1.79%)

Pembina Pipeline…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PBA Pembina Pipeline
$27.39 /

-0.5 (-1.79%)

PBA Pembina Pipeline
$27.39 /

-0.5 (-1.79%)

01/13/21 CIBC
Pembina Pipeline price target raised to C$40 from C$38 at CIBC
12/15/20 BMO Capital
Pembina Pipeline downgraded to Market Perform from Outperform at BMO Capital
11/30/20 Wells Fargo
Pembina Pipeline downgraded to Equal Weight from Overweight at Wells Fargo
11/19/20 Canaccord
Pembina Pipeline price target lowered to C$40 from C$42 at Canaccord
Hot Stocks
Veritone, Base Media Cloud announce six-year agreement » 07:34
01/19/21
01/19
07:34
01/19/21
07:34
VERI

Veritone

$38.75 /

-1.99 (-4.88%)

Veritone with Base Media…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VERI Veritone
$38.75 /

-1.99 (-4.88%)

VERI Veritone
$38.75 /

-1.99 (-4.88%)

12/21/20 Roth Capital
Veritone price target raised to $31 from $20 at Roth Capital
12/21/20 Stifel
Veritone initiated with a Hold at Stifel
11/19/20 Roth Capital
Veritone price target raised to $20 from $18 at Roth Capital
10/06/20 Roth Capital
Veritone energy suite adds to platform's use cases, says Roth Capital
VERI Veritone
$38.75 /

-1.99 (-4.88%)

  • 03
    Dec
VERI Veritone
$38.75 /

-1.99 (-4.88%)

VERI Veritone
$38.75 /

-1.99 (-4.88%)

Initiation
Skillz platform accelerates, Canacord initiates with Buy » 07:33
01/19/21
01/19
07:33
01/19/21
07:33
SKLZ

Skillz

$24.81 /

-1.23 (-4.72%)

As reported previously,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SKLZ Skillz
$24.81 /

-1.23 (-4.72%)

06:37 Today Canaccord
Skillz initiated with a Buy at Canaccord
01/15/21
Fly Intel: Top five analyst initiations
01/15/21 Wells Fargo
Skillz initiated with an Equal Weight at Wells Fargo
01/12/21 Wedbush
Skillz initiated with an Outperform at Wedbush
Hot Stocks
Accuray reports data from phase II trial using TomoTherapy System » 07:32
01/19/21
01/19
07:32
01/19/21
07:32
ARAY

Accuray

$4.76 /

-0.2 (-4.03%)

Accuray announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARAY Accuray
$4.76 /

-0.2 (-4.03%)

ARAY Accuray
$4.76 /

-0.2 (-4.03%)

01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
09/28/20 Lake Street
CMS 'pouring fuel on the fire' for Accuray with APM rule, says Lake Street
09/18/20 Cowen
New CMS model should provide tailwind for Accuray, says Cowen
ARAY Accuray
$4.76 /

-0.2 (-4.03%)

ARAY Accuray
$4.76 /

-0.2 (-4.03%)

Earnings
FMC Corporation cuts Q4 revenue view to about $1.15B from $1.23B-$1.29B » 07:32
01/19/21
01/19
07:32
01/19/21
07:32
FMC

FMC Corporation

$120.03 /

-1.69 (-1.39%)

Q4 consensus $1.26B. FMC…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FMC FMC Corporation
$120.03 /

-1.69 (-1.39%)

FMC FMC Corporation
$120.03 /

-1.69 (-1.39%)

11/20/20
Fly Intel: Top five analyst initiations
11/20/20 Bernstein
FMC Corporation initiated with a Market Perform at Bernstein
11/18/20 BMO Capital
FMC Corporation price target raised to $124 from $120 at BMO Capital
11/18/20 KeyBanc
FMC Corporation price target raised to $137 from $121 at KeyBanc
FMC FMC Corporation
$120.03 /

-1.69 (-1.39%)

Recommendations
Snap price target raised to $60 from $40 at KeyBanc » 07:31
01/19/21
01/19
07:31
01/19/21
07:31
SNAP

Snap

$50.29 /

+1.245 (+2.54%)

KeyBanc analyst Justin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNAP Snap
$50.29 /

+1.245 (+2.54%)

SNAP Snap
$50.29 /

+1.245 (+2.54%)

01/15/21
Fly Intel: Top five analyst upgrades
01/15/21 MoffettNathanson
Snap upgraded to Buy with $57 price target at MoffettNathanson
01/15/21 MoffettNathanson
Snap upgraded to Buy from Neutral at MoffettNathanson
01/12/21 Cowen
Snap price target raised to $62 from $45 at Cowen
SNAP Snap
$50.29 /

+1.245 (+2.54%)

SNAP Snap
$50.29 /

+1.245 (+2.54%)

SNAP Snap
$50.29 /

+1.245 (+2.54%)

SNAP Snap
$50.29 /

+1.245 (+2.54%)

Hot Stocks
Federal court dismisses class action lawsuit against 22nd Century » 07:31
01/19/21
01/19
07:31
01/19/21
07:31
XXII

22nd Century

$2.77 /

-0.05 (-1.77%)

22nd Century Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XXII 22nd Century
$2.77 /

-0.05 (-1.77%)

XXII 22nd Century
$2.77 /

-0.05 (-1.77%)

Recommendations
Assurant price target raised to $170 from $150 at Truist » 07:30
01/19/21
01/19
07:30
01/19/21
07:30
AIZ

Assurant

$31.00 /

+15 (+9.00%)

Truist analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AIZ Assurant
$31.00 /

+15 (+9.00%)

AIZ Assurant
$31.00 /

+15 (+9.00%)

AIZ Assurant
$31.00 /

+15 (+9.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.